Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions

C Clavel, M Masure, I Putaud, K Thomas, JP Bory, R Gabriel, C Quereux and P Birembaut
CHU Reims, France.

AIM: To test a new assay for the detection of human papillomavirus (HPV) DNA, hybrid capture II (HC II), compared with the previous commercialized hybrid capture I (HC I) and polymerase chain reaction (PCR) results on cervical scrapes from fresh cone excision biopsy samples. METHODS: The three methods were used on cervical scrapes from 42 fresh cone excision biopsy samples. There were nine metaplastic and inflammatory lesions, five low grade lesions, and 28 high grade lesions. PCR was performed using the general primers GP5+/GP6+. The viral load of high risk HPV DNA was estimated by the ratio of relative light units to positive control values in the samples. RESULTS: The sensitivity of HC I for the detection of high grade lesions was 71.4%, while it was 92.8% for HC II and 96.4% for the PCR. Considering only the absence of detectable cervical in situ neoplasia, the specificity was 88.9% for HC I, 66.7% for HC II, and 66.7% for PCR. With HC II, for a ratio of cervical sample to normal control of > 200, the sensitivity for the detection of high grade lesion was only 34.6% with a specificity of 66.7%. CONCLUSIONS: HPV detection with the HC II assay is more sensitive than the previous HC I and represents a more convenient and easier test than PCR for routine use. Nevertheless the viral load estimated with this test cannot be a reliable predictive indicator of high grade lesions.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Belinson, S., Smith, J. S., Myers, E., Olshan, A., Belinson, J., Pretorius, R., Qiao, Y.-l., Hartmann, K. (2008). Descriptive Evidence That Risk Profiles for Cervical Intraepithelial Neoplasia 1, 2, and 3 Are Unique. Cancer Epidemiol. Biomarkers Prev. 17: 2350-2355 [Abstract] [Full Text]  
• Fontaine, J., Gravitt, P., Duh, L.-M., Lefevre, J., Pourreaux, K., Hankins, C., Coutlee, F., The Canadian Women's HIV Study Group, (2005). High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens. Cancer Epidemiol. Biomarkers Prev. 14: 2200-2207 [Abstract] [Full Text]  
• Castle, P. E., Lorincz, A. T., Scott, D. R., Sherman, M. E., Glass, A. G., Rush, B. B., Wacholder, S., Burk, R. D., Manos, M. M., Schussler, J. E., Macomber, P., Schiffman, M. (2003). Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer. J. Clin. Microbiol. 41: 4022-4030 [Abstract] [Full Text]  
• Castle, P. E., Wacholder, S., Lorincz, A. T., Scott, D. R., Sherman, M. E., Glass, A. G., Rush, B. B., Schussler, J. E., Schiffman, M. (2002). A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women. JNCI J Natl Cancer Inst 94: 1406-1414 [Abstract] [Full Text]  
• van Diest, P J, Holzel, H (2002). Cervical cancer. J. Clin. Pathol. 55: 241-242 [Full Text]  
• Cubie, H A, Seagar, A L, Beattie, G J, Monaghan, S, Williams, A R W (2000). A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex. Transm. Infect. 76: 257-261 [Abstract] [Full Text]  
• Cox, J. T. (1999). Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings. JAMA 281: 1645-1647 [Full Text]